Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between 18 and 75 years old
- People whose general physical condition is rated at a certain level of functioning (ECOG score of 2 or below — confirm with trial site)
- People who have prostate cancer that has stopped responding to hormone-lowering treatments (castration-resistant prostate cancer), with or without the cancer having spread to other parts of the body
- People whose cancer did not respond to a newer type of hormone therapy
- People whose cancer did not respond to treatment with docetaxel or cabazitaxel (chemotherapy drugs)
- People who have at least one area of cancer that can be measured or assessed on scans
- People whose liver, kidney, lungs, and heart are functioning at acceptable levels based on test results
- People (or their legal guardians) who are willing to take part and sign a consent form
Who may not be able to join:
- People with certain infectious diseases, such as HIV, active hepatitis B or C, or active tuberculosis
- People whose immune cells do not meet the minimum laboratory requirements needed for the treatment to be prepared (confirm with trial site)
- People whose vital signs are unstable or who are unable to cooperate with the study team
- People with a mental illness that would prevent them from cooperating with treatment or assessments
- People with a history of severe allergic reactions, particularly to a substance called IL-2
- People who currently have a serious infection anywhere in the body that requires treatment
- People with significant problems affecting the heart, lungs, brain, liver, or kidneys
- People who have another type of cancer in addition to prostate cancer
- People who the treating doctor considers unsuitable for the trial for other medical reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Junnian Zheng, M.D/Ph.D, The Affiliated Hospital of Xuzhou Medical University
Phone: 0086-17798835021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety Evaluation:Incidence and Severity of Adverse Events; Effectiveness Evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.